BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37865103)

  • 1. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study.
    Eikenboom EL; Moen S; van Leerdam ME; Papageorgiou G; Doukas M; Tanis PJ; Dekker E; Wagner A; Spaander MCW;
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1106-1117. PubMed ID: 37865103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.
    Quezada-Diaz FF; Hameed I; von Mueffling A; Salo-Mullen EE; Catalano A; Smith JJ; Weiser MR; Garcia-Aguilar J; Stadler ZK; Guillem JG
    J Am Coll Surg; 2020 Apr; 230(4):669-675. PubMed ID: 32007537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy.
    Haanstra JF; de Vos Tot Nederveen Cappel WH; Gopie JP; Vecht J; Vanhoutvin SA; Cats A; van der Zaag-Loonen HJ; Langers AM; Bergmann JH; van de Meeberg PC; Dekker E; Kleibeuker JH; Vasen HF; Nagengast FM; van Duijvendijk P
    Dis Colon Rectum; 2012 Jun; 55(6):653-9. PubMed ID: 22595844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.
    International Mismatch Repair Consortium
    Lancet Oncol; 2021 Jul; 22(7):1014-1022. PubMed ID: 34111421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
    Kim TJ; Kim ER; Hong SN; Kim YH; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Kim K; Kim K; Chang DK
    Ann Surg Oncol; 2017 Apr; 24(4):1085-1092. PubMed ID: 27766559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome.
    Renkonen-Sinisalo L; Seppälä TT; Järvinen HJ; Mecklin JP
    Dis Colon Rectum; 2017 Aug; 60(8):792-799. PubMed ID: 28682964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
    Parry S; Win AK; Parry B; Macrae FA; Gurrin LC; Church JM; Baron JA; Giles GG; Leggett BA; Winship I; Lipton L; Young GP; Young JP; Lodge CJ; Southey MC; Newcomb PA; Le Marchand L; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
    Gut; 2011 Jul; 60(7):950-7. PubMed ID: 21193451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
    Messick CA; Kravochuck S; Church JM; Kalady MF
    Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis.
    Malik SS; Lythgoe MP; McPhail M; Monahan KJ
    Fam Cancer; 2018 Oct; 17(4):557-564. PubMed ID: 29189962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-Specific Variation in Colorectal Cancer Surveillance Strategies for Lynch Syndrome.
    Kastrinos F; Ingram MA; Silver ER; Oh A; Laszkowska M; Rustgi AK; Hur C
    Gastroenterology; 2021 Aug; 161(2):453-462.e15. PubMed ID: 33839100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Segmental Colectomy Followed by Endoscopic Surveillance as a Treatment Strategy for Colorectal Cancer Patients with Lynch Syndrome.
    Nagasaki T; Arai M; Chino A; Akiyoshi T; Fukunaga Y; Ueno M
    Dig Surg; 2018; 35(5):448-456. PubMed ID: 29017165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.
    Capelle LG; Van Grieken NC; Lingsma HF; Steyerberg EW; Klokman WJ; Bruno MJ; Vasen HF; Kuipers EJ
    Gastroenterology; 2010 Feb; 138(2):487-92. PubMed ID: 19900449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?
    Anyla M; Lefevre JH; Creavin B; Colas C; Svrcek M; Lascols O; Debove C; Chafai N; Tiret E; Parc Y
    Int J Colorectal Dis; 2018 Jun; 33(6):703-708. PubMed ID: 29532206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes associated with Lynch syndrome colorectal cancer and metachronous rate after subtotal/total versus segmental colectomy: Meta-analysis.
    Toh JWT; Hui N; Collins G; Phan K
    Surgery; 2022 Nov; 172(5):1315-1322. PubMed ID: 36031446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes.
    Goverde A; Eikenboom EL; Viskil EL; Bruno MJ; Doukas M; Dinjens WNM; Dubbink EJ; van den Ouweland AMW; Hofstra RMW; Wagner A; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1112-1120.e1. PubMed ID: 31470178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of metachronous colorectal cancer after colectomy for first colon cancer in Lynch syndrome: multicenter retrospective study in Japan.
    Chikatani K; Ishida H; Mori Y; Nakajima T; Ueki A; Akagi K; Takao A; Yamada M; Taniguchi F; Komori K; Sasaki K; Sudo T; Miyakura Y; Chino A; Yamaguchi T; Tanakaya K; Tomita N; Ajioka Y
    Int J Clin Oncol; 2023 Dec; 28(12):1633-1640. PubMed ID: 37752370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
    Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
    JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease.
    Derikx LA; Smits LJ; van Vliet S; Dekker E; Aalfs CM; van Kouwen MC; Nagengast FM; Nagtegaal ID; Hoogerbrugge N; Hoentjen F
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):454-458.e1. PubMed ID: 27521512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.